设为首页 加入收藏

TOP

SENNALAX TABLETS
2014-10-03 13:25:46 来源: 作者: 【 】 浏览:725次 评论:0
SENNALAX TABLETS

SCHEDULING STATUS:

Not scheduled.

PROPRIETARY NAME:
(and dosage form)

SENNALAX TABLETS

COMPOSITION:
Each tablet contains Senna Dry Extract containing Sennosides A and B equivalent to 7,5 mg Sennoside B.

PHARMACOLOGICAL CLASSIFICATION:
A 11.5 Laxatives.

PHARMACOLOGICAL ACTION:
Sennosides A and B are a natural complex of anthraquinone glycosides found in senna.
The active ingredients (vis. Glycosides) are absorbed from the intestinal tract and the active anthraquinones liberated in the course of breakdown are excreted largely into the colon, which is thereby stimulated.

INDICATIONS:
Constipation.

CONTRA-INDICATIONS:
Undiagnosed abdominal pains and patients with symptoms of appendicitis or intestinal obstruction, nausea and vomiting.

WARNINGS:
Frequent or prolonged use of this preparation may result in dependence on laxatives. If you have noticed a sudden change in bowel habits that has persisted for a period of longer than two weeks, consult a doctor before using the laxative.

DOSAGE AND DIRECTIONS FOR USE:
Adults

The usual dose is between 2 to 4 tablets which may be increased or decreased depending on the response.
Children over the age of 6 years
Half the adult dose.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
The constant use of laxatives to induce a regular daily habit may decrease the sensitivity of the intestinal mucous membranes so that larger doses have to be taken and the bowel fails to respond to normal stimuli.
Abdominal cramps and flatulence may occur.
Melanosis coli and coloration of the urine and faeces have followed the use of Sennalax Tablets.
In the event of continued constipation after the use of this drug for a period of more than one week, consult a physician.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Severe diarrhoea and electrolyte disturbances.
Treatment must be symptomatic with fluid and electrolyte replacement.

IDENTIFICATION:
Thick khaki coloured biconvex tablet.

PRESENTATION:
Packs of 12 tablets.

STORAGE INSTRUCTIONS:
KEEP OUT OF REACH OF CHILDREN

REGISTRATION NUMBER:
Y/11.5/80

NAME AND BUSINESS ADDRESS OF APPLICANT:
Lennon Limited
7 Fairclough Road
PORT ELIZABETH
6001

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
24/7/1990 K95 
以下是“全球医药”详细资料
Tags: 责任编辑:admin
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇THEOPHEN ELIXIR 下一篇BRONCLEER CHILDREN'S COUGH ..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位